Joanne Berger-Sweeney
American neuroscientist and college administrator / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Joanne Berger-Sweeney?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Joanne E. Berger-Sweeney (born September 21, 1958) is an American neuroscientist and the 22nd president of Trinity College, Hartford, Connecticut.[1] She is the first African-American and the first woman to serve in the position. Earlier in her career, Berger-Sweeney did proof-of-concept work on galantamine (brand name Razadyne), the second-most used drug to treat Alzheimer's disease.
Quick Facts Born, Nationality ...
Joanne Berger-Sweeney | |
---|---|
Born | Joanne E. Sweeney (1958-09-21) September 21, 1958 (age 65) Los Angeles, California |
Nationality | American |
Education | Wellesley College (1979 BA) UC Berkeley (1981 MPH) Johns Hopkins Bloomberg School of Public Health (1989 PhD) |
Known for | Proof-of-concept work on galantamine, a drug used to treat Alzheimer's disease |
Spouse | Urs V. Berger |
Children | 2 |
Awards | Alumni Achievement Award, Johns Hopkins University (2015) Posse Star, Posse Foundation (2017) |
Scientific career | |
Fields | Neuroscience |
Institutions | Trinity College (Connecticut) |
Doctoral advisor | Joseph T. Coyle Yvon Lamour |
Doctoral students | Elizabeth A. Buffalo |
Signature | |
Close